稳定预注射SARS-CoV-2尖端通过破坏融合后形状的稳定.
Debajyoti Chakraborty1, Randhir Singh2, Raju S Rajmani1
1Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.
Vaccines
|April 23, 2025
概括
将带电氨基酸引入SARS-CoV-2尖端蛋白质,增强了其表达和稳定性. 这种新的方法,破坏了融合后形式的稳定性,为改善疫苗的病毒表面蛋白质产量提供了一个总体策略.
科学领域:
- 结构生物学是结构生物学.
- 疫苗的研发工作正在进行中.
- 病毒学 病毒学
背景情况:
- 本地SARS-CoV-2尖刺蛋白是转移稳定的.
- 目前的COVID-19疫苗使用稳定的Spike变种 (Spike-2P,Spike-6P) 与替代物.
- 另一种策略是破坏融合后形状的稳定.
研究的目的:
- 为了研究将两个酸残留物 (2D) 引入Spike蛋白的HR1区域的效果.
- 为了提高预注射尖峰形状的产量和稳定性.
- 为了评估修改后的Spike变种的免疫性和保护效果.
主要方法:
- 哺乳动物细胞培养中的重组蛋白表达.
- 蛋白质产量和抗原性的表征.
- 对仓鼠进行免疫接种,然后对其进行活体SARS-CoV-2 B.1.351变种的挑战.
主要成果:
- 2D突变增加了蛋白质表达的6倍.
- 结合2D与四个普罗林突变 (Spike-4P-2D) 进一步增强了表达.
- 所有测试的Spike变种 (2P,2D,6P,4P-2D) 都保护了仓鼠免受SARS-CoV-2挑战,并诱导了高中和抗体标位.
结论:
- 通过引入带电氨基酸来破坏融合后构造的稳定性,可以提高病毒表面蛋白质的产量和稳定性.
- 这一策略为改善疫苗开发的病毒蛋白表达提供了一种通用方法.
- 2D突变策略显示出开发更有效的疫苗的前景.
更多相关视频
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
33.1K
06:39High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
3.0K
相关概念视频
SNAREs and Membrane Fusion
9.3K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
9.3K
Fusion of Secretory Vesicles with the Plasma Membrane
9.5K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
9.5K
